Pages that link to "Q37861039"

The following pages link to T-cell clones that react against autologous human tumors (Q37861039):

Displaying 19 items.

• Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA (Q24601273) (← links)
• Clinical implications of the new biology in the development of melanoma vaccines (Q33603062) (← links)
• Advances in gene therapy for malignant melanoma (Q34119859) (← links)
• Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials (Q34446288) (← links)
• Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. (Q35595698) (← links)
• Cancer vaccine development: on the way to break immune tolerance to malignant cells. (Q35879344) (← links)
• Part I: Vaccines for solid tumours (Q35937453) (← links)
• Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy (Q38253084) (← links)
• Cancer escape from immune surveillance: How can it be overcome by gene transfer? (Q40470697) (← links)
• Recognition of autoantigens by patients with melanoma (Q40844530) (← links)
• Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy (Q41542882) (← links)
• Update on active specific immunotherapy with melanoma vaccines (Q41589321) (← links)
• Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin (Q43509085) (← links)
• Clinical trials with VMO for melanoma (Q44772535) (← links)
• Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model (Q45778750) (← links)
• Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients (Q46515514) (← links)
• Interferon beta enhances the natural killer activity of patients with bladder carcinoma. (Q54202559) (← links)
• Isolation and In vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: Functional and molecular characterisation for their use in adoptive immunotherapy (Q61719181) (← links)
• Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha (Q71703742) (← links)